Safety and Efficacy of Firmagon® (Degarelix) for Injection
Status:
Completed
Trial end date:
2019-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of Firmagon® (degarelix) for
injection under the conditions of general clinical practice in Korea.